NEW PRODUCT
3D/4D Ultrasound System
Medison USA (www.medison usa.com) announces the launch of its new ACCUVIX V20 3D/4D ultrasound model. The ergonomic design includes a large 10.4" LCD intuitive touch panel and an articulated arm to provide comfort and functionality. ACCUVIX V20's fundamental operating system, VolumeOS, is easy for users who have relatively little experience with 3D/4D diagnoses. For users accustomed to such diagnoses, the system minimizes redundant time.
NEW PRODUCT
Respiratory Software System for Optimal Radiotherapy Positioning
Dyn'R (www.dynr.com) announces SpiroDyn'rX (SDX), designed to help more accurately position the lungs during radiotherapy.
SDX consists of a spirometer and video glasses combination located in the imaging or treatment room and software installed in the control room. The patient breathes into the spirometer while wearing the glasses. An operator monitoring the process from a computer in the control room determines optimal levels based on the software's illustration of the patient's inhalation and exhalation. The "optimal inspiration zone" is then displayed in the patient's video glasses as a colored bar, helping the patient aim for the desired levels during imaging or treatment.
NEW PRODUCT
Portable Detector for Digital Radiography
Canon USA (www.usa.canon.com) expands its line of digital radiography systems with the CXDI-60G portable flat panel detector. Weighing 5.9 pounds and measuring less than an inch thick, the CXDI-60G offers an effective imaging area of 9 x 11 inches, accommodating a diverse range of applications such as X-rays of hands, elbows, feet and knees.
The CXDI-60G provides a variety of configuration options to fit individual facility requirements and delivers high-quality images with minimal radiation exposure to patients. Images can be confirmed on an optional preview monitor approximately three seconds after exposure.
FDA CLEARANCE
Liver-Specific MR Contrast
Bayer HealthCare Pharmaceuticals (pharma.bayer.com) has received FDA approval for its EOVIST® (gadoxetate disodium), an injectable gadolinium-based contrast agent. Designed for intravenous use in T1-weighted MR imaging of the liver, EOVIST helps detect and characterize lesions in adult patients with known or suspected focal liver disease.
EOVIST is a paramagnetic contrast solution that combines features of both an extracellular contrast agent and a hepatocyte-specific agent. Given intravenously by bolus injection, it has a dual route of excretion, with approximately half eliminated through the liver and half eliminated through the kidney.

Information for Product News came from the manufacturers. Inclusion in this publication should not be construed as a product endorsement by RSNA. To submit product news, send your information and a non-returnable color photo to RSNA News, 820 Jorie Blvd., Oak Brook, IL 60523 or by e-mail to rsnanews@rsna.org. Information may be edited for purposes of clarity and space.